Skip to main content
. 2023 Jul 26;13:12137. doi: 10.1038/s41598-023-39369-y

Figure 1.

Figure 1

Protocol for derivation of hiPSC-cFbs using CHIR99021 (GSK-3 inhibitor), IWR-1-endo (Wnt/beta-catenin inhibitor), Retinoic acid and Fibroblast Growth Factor 234. SB431542 is a TGF-β receptor type 1 inhibitor.